Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3

NCT05715736 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Still's Disease, Adult-Onset

Interventions

DRUG: APB-R3
DRUG: Placebo

Sponsor

Syneos Health

Collaborators

[object Object]